Or they'll make other. They'll make other choices. And that's actually the beauty of a dynamic free market system. I would say in pharmaceuticals, if you take it from a global perspective, We've not had a dynamic free market system [in pharmaceuticals]. We've had a system of heavy subsidization, most of it coming from the United States. being put on the backs of the American people. And most favored nation brings that. Thank you. Thank you, everybody. I really appreciate. (1:00:50–1:01:03)
CLAIM
Asserts that the global pharmaceutical market is not a dynamic free market due to U.S. subsidization.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
